For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Universitéde Montreal

USPTO Granted Patents = 183

CIPO Patents = 22

EPO Patents = 53

Forward Citations = 2,080

Loading Chart...

Loading Chart...

387 inventors (with patents filed for the assignee):

Nathalie Ravet (18 out of 27 patents)

Michel Armand (15 out of 72 patents)

Christophe Michot (15 out of 58 patents)

4. Michel Gauthier (11 out of 81 patents)

5. Jocelyn Faubert (10 out of 17 patents)

6. Guy Sauvageau (10 out of 12 patents)

7. Christer Sinderby (9 out of 31 patents)

8. Jean-François Magnan (8 out of 31 patents)

9. Edward H Ruediger (8 out of 52 patents)

10. Michel Bouvier (8 out of 13 patents)

11. Jacques Banville (8 out of 27 patents)

12. Shoshana L Posy (7 out of 33 patents)

13. Eldon Scott Priestley (7 out of 23 patents)

14. Stéphane Gingras (7 out of 8 patents)

15. Anne Marinier (7 out of 22 patents)

Core Competencies:

Pyrido Compounds

Heterocyclic Inhibitors

Cyclic Peptides

Biarylmethyl Heterocycles

Stem Cell Expansion

Optical Systems

Biosensors

Minor Histocompatibility Antigens

Protease Activated Receptor Inhibitors

Sphingolipid-like Molecules

Tumor-specific Antigens

Visual Exploration Strategy

183 patents: Sort by Forward Citations

1. 12479842 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease (2025-11-25),

2. 12386199 - Method for determining a progressive lens and associated system (2025-08-12),

3. 12360400 - Method for determining a progressive lens and associated system (2025-07-15),

4. 12286559 - Method for plasma deposition of anti-fog coatings (2025-04-29),

5. 12286426 - Heterocyclic mitochondrial activity inhibitors and uses thereof (2025-04-29),

6. 12139488 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease (2024-11-12),

7. 12092903 - Method for adapting ophthalmic equipment according to a wearers visual exploration strategy (2024-09-17),

8. 12084452 - Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation (2024-09-10),

9. 12060353 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease (2024-08-13),

10. 12038628 - Method and system for determining an optical system intended to equip a person on the basis of the adaptability of the person to a visual and/or proprioceptive modification of his/her environment (2024-07-16),

11. 12037324 - Biarylmethyl heterocycles (2024-07-16),

12. 12011460 - Expansion of NK and DC cells in vivo mediating immune response (2024-06-18),

13. 11879021 - Cyclic peptides and uses thereof (2024-01-23),

14. 11760754 - Heterocyclic mitochondrial activity inhibitors and uses thereof (2023-09-19),

15. 11725187 - Selection of human hematopoetic stem cells using EPCR (2023-08-15),

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

183 Patents

#8 in Montreal

#62 in Canada

#4,440 in the World

Montreal, Canada

Universitéde Montreal

Forward Citations = 2,080

387 inventors:

Nathalie Ravet (18 out of 27 patents)

Michel Armand (15 out of 72 patents)

Christophe Michot (15 out of 58 patents)

4. Michel Gauthier (11 out of 81 patents)

5. Jocelyn Faubert (10 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…